Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Mouse IL-28B/IFN-lambda 3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 1789ML025
This item is not returnable.
View return policy
Description
Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.800-8.00 ng/mL.Specifications
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
19.7 kDa | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. | |
Unconjugated | |
Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
338374 | |
IL-28B/IFN-lambda 3 | |
E. coli-derived mouse IL-28B/IFN-lambda 3 protein Asp20-Val193,with an N-terminal Met | |
<0.10 EU per 1μg of the protein by the LAL method. | |
Recombinant | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction